“Portola is fortunate to have the confidence of high quality venture capitalists and institutional investors. Their unwavering commitment to our company and mission has been invaluable to our progress thus far.”
—Mardi Dier,
Portola CFO
Investors
Portola has raised funds in financings with prominent investors of the biotechnology industry:
- Abingworth Management
- Adage Capital
- Advance Technology Ventures
- AllianceBernstein
- Alta Partners
- Apothecary Capital
- Brookside Capital
- China Investment and Development
- DE Shaw
- Eastern Capital Limited
- Frazier Healthcare
- Goldman Sachs Investment Partners
- IBT Management Corp.
- Janus Capital
- MPM Capital
- PAC-LINK BioVentures
- Prospect Ventures
- Sutter Hill Ventures
- T. Rowe Price
- Teachers’ Private Capital
- Temasek